First Manhattan’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-188,985	Closed	-$749K	–	1494
2018 Q4	$749K	Sell	188,985 -125,075	-40%	-$496K	﹤0.01%	478
2018 Q3	$6.2M	Buy	314,060 +74,060	+31%	+$1.46M	0.03%	239
2018 Q2	$7.62M	Buy	+240,000	New	+$7.62M	0.04%	215